Liquid-based cytology: Evaluation of effectiveness, cost-effectiveness, and application to present practice

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 2, Issue 6, 2004, Pages 597-611

  Cox, J Thomas ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b 3M COMPANY   (United States)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia grade 2 or 3 (CIN 2,3); Conventional Papanicolaou smear; Human papillomavirus (HPV) testing; Liquid based cytology (LBC)

Indexed keywords

ANALYTICAL EQUIPMENT; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; CYTOLOGY; ECONOMICS; EVALUATION; FEMALE; HUMAN; METHODOLOGY; PATHOLOGY; PRODUCTIVITY; REVIEW; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COST-BENEFIT ANALYSIS; CYTOLOGICAL TECHNIQUES; EFFICIENCY; FEMALE; HUMANS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 58149386693     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2004.0050     Document Type: Article

References (118)

1. U. S. Preventative Services Task Force. Guide to clinical preventative services. Washington D.C.: US Sept of Health and Human Services; 2003.
2. Cox JT. Evaluation of abnormal cervical cytology. Clin Lab Med. 2000;20:303-43.
3. Ries LAG, Kosary CL, Hankey BF, et al., eds. SEER Cancer Statistics Review, 1973-1996. Bethesda, MD: National Cancer Institute; 1999.
4. Cancer Incidence in Five Continents, vol. VII. Lyon, France: International Agency for Research on Cancer; 1997.
5. American Cancer Society, Cancer Facts & Figures 1997-2004. Available at http://www.cancer.org. Accessed October 2004.
6. Healthy People 2010. Available at http://www.healthypeople. gov. Accessed October 2004.
7. Cervical cancer. NIH Consensus Statement. Washington, D.C.: National Institutes of Health; 1996;14:1-38.
8. Saslow D, Runowicz CD, Solomon D, et al., for the American Cancer Society. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342-362.
9. Papanicolaou GN, Traut HF. Diagnosis of Uterine Cancer by the Vaginal Smear. New York, NY: Commonwealth Fund; 1943.
10. Bogdanich W. The Pap test misses much cervical cancer through lab error. Wall Street Journal. Nov. 2, 1987: p. 1.
11. Clinical Laboratory Improvement Amendments of 1988, 42 Washington, DC. Federal Registry. Part 405.1992;57:7169.
12. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnosis. JAMA 1989;262:931-934.
13. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-689.
14. Evidence Report/Technology Assessment: Number 5. Rockville, MD: Agency for Health Care Policy and Research; 1999.
15. Klinkhamer PJ, Meerding WJ, Rosier PF, et al. Liquid-based cervical cytology. Cancer. 2003;99:263-271.
16. Hurley AA, Douglass KL, Zahniser DJ. Improved technology for cytology specimen preparation. Am Clin Lab 1991;10:20-22.
17. Stoler MH. Advances in cervical screening technology. Mod Pathol 2000;13:275-284.
18. Hutchinson ML, Isenstein LM, Goodman A, et al. Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor. Am J Clin Pathol. 1994;101:215-219.
19. Zahniser DJ, Hurley AA. Automated slide preparation system for the clinical laboratory. Cytometry. 1996;26: 60-64.
20. Braly P, Kinney W, Sheets E, et al. Reporting the potential benefits of new technologies for cervical cancer screening. J Low Gen Tract Dis 2000;5:73-81.
21. Gupta PK, Baloch ZW, Cobbs C, et al. Processing liquidbased gynecologic specimens: comparison of the available techniques. Acta Cytol. 2001;45:995-998.
22. Bishop JW, Bigner SH, Colgan TJ, et al. Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. Including initial biopsy results. Acta Cytol. 1998;42:189-197.
23. Tench W. Preliminary assessment of the AutoCyte PREP. Direct-to-vial performance. J Reprod Med. 2000;45: 912-916.
24. Karnon J, Peters J, Platt J, et al. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess. 2004;8:1-78.
25. Payne N, Chilcott J, McGoogan E. Liquid-based cytology in cervical screening: a rapid and systematic review. Health Technol Assess. 2000;4:1-73.
26. Hutchinson ML, Cassin CM, Ball HG. The efficacy of an automated preparation device for cervical cytology. Am J Clin Pathol 1991;96:300-305.
27. Hutchinson ML, Agarwal P, Denault T, et al. A new look at cervical cytology. ThinPrep multicenter trial results. Acta Cytol 1992;36:499-504.
28. Awen C, Hathway S, Eddy W, et al. Efficacy of ThinPrep preparation of cervical smears: A 1,000-case, investigatorsponsored study. Diagn Cytopathol 1994;11:33-36; discussion 36-37.
29. Wilbur DC, Cibas ES, Merritt S, et al. ThinPrep Processor: Clinical trials demonstrate an increased detection rate of abnormal cervical cytologic specimens. Am J Clin Pathol 1994; 101:209-214.
30. Laverty CR, Thurloe JK, Redman NL, Farnsworth A. An Australian trial of ThinPrep: A new cytopreparatory technique. Cytopathology 1995;6:140-148.
31. Aponte-Cipriani SL, Teplitz C, Rorat E, et al. Cervical smears prepared by an automated device versus the conventional method: A comparative analysis. Acta Cytol 1995;39:623-630.
32. Sheets EE, Constantine NM, Dinisco S, et al. Colposcopically directed biopsies proived a basis for comparing the accuracy of ThinPrep and Papanicolaou smears. J Gynecol Techn 1995;1:27-33.
33. Bur M, Knowles K, Pekow P, et al. Comparison of ThinPrep preparations with conventional cervicovaginal smears: Practical considerations. Acta Cytol 1995;39:631-642.
34. Tezuka F, Oikawa H, Shuki H, Higashiiwai H. Diagnostic efficacy and validity of the ThinPrep method in cervical cytology. Acta Cytol 1996;40:513-518.
35. Ferenczy A, Robitaille J, Franco E, et al. Conventional cervical cytologic smears vs. ThinPrep smears: A paired comparison study on cervical cytology. Acta Cytol 1996;40: 1136-1142.
36. Wilbur DC, Dubeshter B, Angel C, Atkison KM. Use of thin-layer preparations for gynecologic smears with emphasis on the cytomorphology of high-grade intraepithelial lesions and carcinomas. Diagn Cytopathol 1996;14: 201-211.
37. Lee KR, Ashfaq R, Birdsong GG, et al. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 1997;90:278-284.
38. Roberts JM, Gurley AM, Thurloe JK, et al. Evaluation of the ThinPrep Pap test as an adjunct to the conventional Pap smear. Med J Aust 1997;167:466-469.
39. Corkill M, Knapp D, Hutchinson ML. Improved accuracy for cervical cytology with the ThinPrep method and the endocervical brush-spatula. J Low Gen Tract Dis 1998;2: 12-16.
40. Hutchinson ML, Zahniser DJ, Sherman ME, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 1999;87:48-55.
41. Wang TY, Chen HS, Yang YC, Tsou MC. Comparison of fluid-based, thin-layer processing and conventional Papanicolaou methods for uterine cervical cytology. J Formos Med Assoc 1999;98:500-505.
42. Monsonego J, Autillo-Touati A, Bergeron C, et al. Liquidbased cytology for primary cervical cancer screening: a multi-centre study. Br J Cancer 2001;84:360-366.
43. Park IA, Lee SN, Chae SW, et al. Comparing the accuracy of ThinPrep Pap tests and conventional Papanicolaou smears on the basis of the histologic diagnosis: A clinical study of women with cervical abnormalities. Acta Cytol 2001;45:525-531.
44. Biscotti CV, O'Brien DL, Gero MA, et al. Thin-layer Pap test vs. conventional Pap smear: Analysis of 400 split samples. J Reprod Med 2002;47:9-13.
45. Luthra UK, Chishti M, Dey P, et al. Performance of monolayered cervical smears in a gynecology outpatient setting in Kuwait. Acta Cytol 2002;46:303-310.
46. Ring M, Bolger N, O'Donnell M, et al. Evaluation of liquid-based cytology in cervical screening of high-risk populations: A split study of colposcopy and genitourinary medicine populations. Cytopathology 2002;13:152-159.
47. Vassilakos P, Cossali D, Albe X, et al. Efficacy of monolayer preparations for cervical cytology: Emphasis on suboptimal specimens. Acta Cytol 1996;40:496-500.
48. Takahashi M, Naito M. Application of the CytoRich monolayer preparation system for cervical cytology: A prelude to automated primary screening. Acta Cytol 1997;41: 1785-1789.
49. Howell LP, Davis RL, Belk TI, et al. The AutoCyte preparation system for gynecologic cytology. Acta Cytol 1998;42:171-177.
50. Geyer JW, Hancock F, Carrico C, Kirkpatrick M. Preliminary evaluation of Cyto-Rich: An improved automated cytology preparation. Diagn Cytopathol 1993;9: 417-422.
51. Sprenger E, Schwarzmann P, Kirkpatrick M, et al. The false negative rate in cervical cytology: Comparison of monolayers to conventional smears. Acta Cytol 1996;40: 81-89.
52. Bishop JW. Comparison of the CytoRich system with conventional cervical cytology: Preliminary data on 2,032 cases from a clinical trial site. Acta Cytol 1997;41:15-23.
53. Laverty CR, Farnsworth A, Thurloe JK, et al. Evaluation of the CytoRich slide preparation process. Anal Quant Cytol Histol 1997;19:239-245.
54. Wilbur DC, Facik MS, Rutkowski MA, et al. Clinical trials of the CytoRich specimen-preparation device for cervical cytology: Preliminary results. Acta Cytol 1997;41: 24-29.
55. Stevens MW, Nespolon WW, Milne AJ, Rowland R. Evaluation of the CytoRich technique for cervical smears. Diagn Cytopathol. 1998;18:236-42.
56. Minge L, Fleming M, VanGeem T, Bishop JW. AutoCyte Prep system vs. conventional cervical cytology: Comparison based on 2,156 cases. J Reprod Med 2000;45:179-184.
57. Bergeron C, Bishop J, Lemarie A, et al. Accuracy of thinlayer cytology in patients undergoing cervical cone biopsy. Acta Cytol 2001;45:519-524.
58. Weintraub J, Wenger D. A large-scale investigator-sponsored field study of the test performance of the ThinPrep Papanicolaou test in a low-risk routine outpatient setting. Prim Care Update Ob Gyns 1998;5:164.
59. Bolick DR, Hellman DJ. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol 1998;42:209-213.
60. Dupree WB, Suprun HZ, Beckwith DG, et al. The promise and risk of a new technology: The Lehigh Valley Hospital's experience with liquid-based cervical cytology. Cancer 1998;84:202-207.
61. Papillo JL, Zarka MA, St John TL. Evaluation of the ThinPrep Pap test in clinical practice: A seven-month, 16,314-case experience in northern Vermont. Acta Cytol 1998;42:203-208.
62. Vassilakos P, Griffin S, Megevand E, Campana A. CytoRich liquid-based cervical cytologic test: Screening results in a routine cytopathology service. Acta Cytol 1998;42: 198-202.
63. Vassilakos P, Saurel J, Rondez R. Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories. Acta Cytol 1999;43:65-68.
64. Carpenter AB, Davey DD. ThinPrep Pap Test: Performance and biopsy follow-up in a university hospital. Cancer. 1999;87:105-112.
65. Diaz-Rosario LA, Kabawat SE. Performance of a fluid-based, thin-layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Arch Pathol Lab Med 1999;123:817-821.
66. Guidos BJ, Selvaggi SM. Use of the Thin Prep Pap Test in clinical practice. Diagn Cytopathol 1999;20:70-73.
67. Weintraub J, Morabia A. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer. Diagn Cytopathol 2000;22:52-59.
68. Ferris DG, Heidemann NL, Litaker MS, Crosby JH, Macfee MS. The efficacy of liquid-based cervical cytology using directto-vial sample collection. J Fam Pract. 2000;49: 1005-11.
69. Marino JF, Fremont-Smith M. Direct-to-vial experience with AutoCyte PREP in a small New England regional cytology practice. J Reprod Med 2001;46:353-358.
70. Day SJ, Deszo EL, Freund GG. Dual sampling of the endocervix and its impact on AutoCyte Prep endocervical adequacy. Am J Clin Pathol 2002;118:41-46.
71. Baker JJ. Conventional and liquid-based cervicovaginal cytology: A comparison study with clinical and histologic follow-up. Diagn Cytopathol 2002;27:185-188.
72. Bernstein SJ, Sanchez-Ramos L, Ndubisi B. Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a meta-analysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 2001;185:308-317.
73. Sherman ME. Chapter 11: Future directions in cervical pathology. J Natl Cancer Inst Monogr 2003;31:72-79.
74. Renshaw AA, Young NA, Birdsong GG, et al. Comparison of performance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program. Arch Pathol Lab Med 2004; 128:17-22.
75. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-819.
76. Sulik SM, Kroeger K, Schultz JK, et al. Are fluid-based cytologies superior to the conventional Papanicolaou test? A systematic review. J Fam Pract 2001;50:1040-1046.
77. Abulafia O, Pezzullo JC, Sherer DM. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol 2003;90:137-144.
78. Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84:1616-1623.
79. Belinson J, Qiao YL, Pretorius R et al. Shanxi Province Cervical Cancer Screening Study: A cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-444.
80. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-1757.
81. Obwegeser JH, Brack S. Does liquid-based technology really improve detection of cervical neoplasia? A prospective randomized trial comparing the ThinPrep Pap Test with the conventional Pap Test including follow-up of HSIL cases. Acta Cytol 2001;45:709-714.
82. Schledermann D, Ejersbo D, Hoelund B. Significance of atypia in conventional Papanicolaou smears and liquid-based cytology: a follow-up study. Cytopathology 2004;15:148-153.
83. Negri G, Menia E, Egarter-Vigl E, et al. ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up of women with equivocal cervical smears. Cancer 2003;99: 342-345.
84. Uyar DS, Eltabbakh GH, Mount SL. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. Gynecol Oncol 2003;89: 227-232.
85. Chacho MS, Mattie ME, Schwartz PE. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison. Cancer 2003; 99:135-140.
86. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-1044.
87. Mitchell H, Hocking J, Saville M. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening. Cancer 2003;99:336-341.
88. Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F. ThinPrep Pap Test. Accuracy for glandular disease. Acta Cytol 1999;43:81-85.
89. Bai H, Sung CJ, Steinhoff MM. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix. Diagn Cytopathol 2000;23:19-22.
90. Hecht JL, Sheets EE, Lee KR. Atypical glandular cells of undetermined significance in conventional cervical/vaginal smears and thin-layer preparations. Cancer 2002;96:1-4.
91. Schorge JO, Hossein Saboorian M, Hynan L, et al. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study. Cancer 2002;96:338-343.
92. Studeman KD, Ioffe OB, Puszkiewicz J, et al. Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology. Acta Cytol 2003;47: 605-610.
93. Belinson JL, Pan QJ, Biscotti C, et al. Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples. Acta Cytol 2002;46:470-474.
94. Michael CW, McConnel J, Pecott J, et al. Comparison of ThinPrep and TriPath PREP liquid-based preparations in nongynecologic specimens: a pilot study. Diagn Cytopathol 2001;25:177-184.
95. Castle PE, Solomon D, Hildesheim A, et al. Stability of archived liquid-based cervical cytologic specimens. Cancer 2003;99:89-96.
96. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610.
97. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-1392.
98. Levi AW, Kelly DP, Rosenthal DL, et al. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods. Cancer 2003;99:191-197.
99. Wright TC Jr, Cox JT, Massad LS et al. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.
100. Noller KL, Bettes B, Zinberg S, et al. Cervical cytology screening practices among obstetrician-gynecologists. Obstet Gynecol 2003;102:259-265.
101. Zuna RE, Moore W, Dunn ST. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor. Mod Pathol 2001;14:147-151.
102. Kohl KS, Markowitz LE, Koumans EH. Developments in the screening for Chlamydia trachomatis: a review. Obstet Gynecol Clin North Am 2003;30:637-658.
103. Koumans EH, Black CM, Markowitz LE, et al. Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid Pap smear medium. J Clin Microbiol 2003;41:1507-1511.
104. Darwin LH, Cullen AP, Arthur PM, et al. Comparison of Digene hybrid capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol 2002;40: 641-644.
105. Brown AD, Garber AM. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA 1999;281:347-353.
106. Sawaya GF, Brown AD, Washington AE, et al. Clinical practice. Current approaches to cervical-cancer screening. N Engl J Med 2001;344:1603-1607.
107. Ward J. Population-based mammographic screening: Does 'informed choice' require any less than full disclosure to individuals of benefits, harms, limitations, and consequences? Aust N Z J Public Health 1999;23: 301-304.
108. Ward M, Marteau TM, Senior V, et al. Women's understanding of a "normal smear test result": Experimental questionnaire based study. Br Med J 2001;322:526-528.
109. Kim JJ, Wright TC, Goldie SJ. Cost effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390.
110. ACOG Practice Bulletin. Cervical cytology screening. Washington, DC: American College of Obstetricians and Gynecologists; 2003.
111. U. S. Preventative Services Task Force. Guide to clinical preventative services. Washington, D.C.: US Sept of Health and Human Services; 2003.
112. Centers for Disease Control. CDC guideline for immunocompromised women; USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodefiency virus: A summary. Morb Mortal Wkly Rep 1995;44(RR-8):1-34.
113. Yeoh GP, Chan KW. Cell block preparation on residual ThinPrep sample. Diagn Cytopathol 1999;21:427-431.
114. Rappaport KM, Forrest CB, Holtzman NA. Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists. Health Serv Res 2004;39: 927-947.
115. Marchand L, Van Dinter M, Mundt M, et al. Current cervical cancer screening practices of Dane County, Wisconsin primary care clinicians. WMJ 2003;102:35-40.
116. Anhang R, Goodman A, Goldie SJ. HPV communication: Review of existing research and recommendations for patient education. Cancer J Clin 2004;64:248-259.
117. Hildebrandt EF, Lee JR, Crosby JH, et al. Liquid-based pap smears as a source of RNA for gene expression analysis. Appl Immunohistochem Mol Morphol 2003;11: 345-351.
118. Yoshida T, Fukuda T, Sano T, et al. Usefulness of liquidbased cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Cancer 2004;102:100-108.